Anne Sadewasser
Research Subjects
Anne Sadewasser has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Barbara Vetter
Labor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany
1 shared publicationBoris Bogdanow
Max Delbrück Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125, Berlin, Germany
1 shared publicationElda Kutrolli
Lipigon Pharmaceuticals AB, Umeå, Sweden
1 shared publicationFrank Jaschinski
Secarna Pharmaceuticals GmbH & Co. KG, Planegg, Germany
1 shared publicationGunilla Olivecrona
Lipigon Pharmaceuticals AB, Umeå, Sweden; Department of Medical Biosciences, Umeå University, Umeå, Sweden
1 shared publicationImmanuel Husic
Max Delbrück Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125, Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 3 June 2022
- Published by Elsevier in Journal of Lipid Research
- Vol. 63 (7) , 100237
ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy
- 3 June 2022
- Published by Elsevier in Journal of Lipid Research
- Vol. 63 (7) , 100237
Open AccessANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy
- Open Access
- 4 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
The dynamic proteome of influenza A virus infection identifies M segment splicing as a host range determinant
Pandemic influenza A virus (IAV) outbreaks occur when strains from animal reservoirs acquire the ability to infect and spread among humans. The molecular basis of this species barrier is incompletely understood. Here we combine metabolic pulse labeling and quantitative proteomics to monitor protein synthesis upon infection of human cells with a human- and a bird-adapted IAV strain and observe striking differences in viral protein synthesis. Most importantly, the matrix protein M1 is inefficiently produced by the bird-adapted strain. We show that impaired production of M1 from bird-adapted strains is caused by increased splicing of the M segment RNA to alternative isoforms. Strain-specific M segment splicing is controlled by the 3′ splice site and functionally important for permissive infection. In silico and biochemical evidence shows that avian-adapted M segments have evolved different conserved RNA structure features than human-adapted sequences. Thus, we identify M segment RNA splicing as a viral host range determinant.
- 4 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
Open AccessThe dynamic proteome of influenza A virus infection identifies M segment splicing as a host range determinant
Pandemic influenza A virus (IAV) outbreaks occur when strains from animal reservoirs acquire the ability to infect and spread among humans. The molecular basis of this species barrier is incompletely understood. Here we combine metabolic pulse labeling and quantitative proteomics to monitor protein synthesis upon infection of human cells with a human- and a bird-adapted IAV strain and observe striking differences in viral protein synthesis. Most importantly, the matrix protein M1 is inefficiently produced by the bird-adapted strain. We show that impaired production of M1 from bird-adapted strains is caused by increased splicing of the M segment RNA to alternative isoforms. Strain-specific M segment splicing is controlled by the 3′ splice site and functionally important for permissive infection. In silico and biochemical evidence shows that avian-adapted M segments have evolved different conserved RNA structure features than human-adapted sequences. Thus, we identify M segment RNA splicing as a viral host range determinant.